Haemonetics
HAE
HAE
296 hedge funds and large institutions have $4.3B invested in Haemonetics in 2023 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 98 increasing their positions, 111 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 38
12% less repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 111
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
296
Holding in Top 10
1
Calls
$8.4M
Puts
$2.21M
Top Buyers
| 1 | +$34.7M | |
| 2 | +$23M | |
| 3 | +$19M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.6M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$8.23M |
Top Sellers
| 1 | -$32.3M | |
| 2 | -$30.8M | |
| 3 | -$18.9M | |
| 4 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
-$14M |
| 5 |
CCM
Cinctive Capital Management
New York
|
-$9.95M |